Medicine Man Technologies, Inc.

SHWZ

Explore Our Financial Data > Companies > Medicine Man Technologies, Inc.
{{popupValue}}
{{popupSubtitle}}
Documentation
Excel
API
Download

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
SHWZ
CIK0001622879
SIC8742
SectorServices
Industry CategoryBusiness Services
Industry GroupServices – Management, Public Relations, Consulting

Contact

Address865 N. ALBION ST., SUITE 300, DENVER, CO, 80220
Website schwazze.com
Phone303-371-0387
CEON/A
Employees390

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$172.45 million
Pre-Tax Income$-14.81 million
Net Income$-34.55 million
Net Income to Common$-42.70 million
EPS$-0.66
View All
Balance Sheet
Cash$19.25 million
Assets$358.14 million
Liabilities$238.85 million
Common Equity$119.29 million
Liabilities & Equity$358.14 million
View All
Cash Flow Statement
Net Income$-34.55 million
Cash From Operating Activities$12.20 million
Cash From Investing Activities$-26.44 million
Cash From Financing Activities$-5.46 million
Change in Cash$-19.70 million
View All
Calculations
NOPAT$2.30 million
EBITDA$48.40 million
Price to EarningsN/A
Price to Book$0.01
ROE-27.48%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Schwazze Provides Update on Delayed Filings

DENVER, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), is providing an update on its previously announced delayed filings. On November 29, 2024, the Audit Committee of the Company determined, following discussions with Baker Tilly and the Company’s management, that the Company’s previously issued audited consolidated financial statements for the two fiscal years ended December 31, 2023, audited

Article Link

Schwazze Announces Preliminary Third Quarter 2024 Financial Results

Optimization Initiatives Lead to Quarter-over-Quarter Improvements in Profitability and Positive Cash Flow from OperationsDENVER, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), today announced preliminary financial and operational results for the third quarter ended September 30, 2024. “We continued to generate momentum from our retail growth and optimization initiatives in Q3, reflected by our

Article Link

Schwazze Announces Second Quarter 2024 Financial Results

Growth and Restructuring Initiatives Lead to Quarter-over-Quarter Growth Across all Key Financial Metrics in Q2 Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time DENVER, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), today announced financial and operational results for the second quarter ended June 30, 2024. “We made solid progress on our growth and optimization initia

Article Link

Schwazze Sets Second Quarter 2024 Conference Call for August 13, 2024 at 5:00 p.m. ET

DENVER, July 30, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Tuesday, August 13, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the second quarter ended June 30, 2024. The Company’s results will be reported in a press release prior to the call. The Schwazze management team will host the conference call, followed by a question-and-answ

Article Link

Schwazze Announces Restructuring of February 2025 Debt Obligations

DENVER, Colo., July 11, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCPK: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), today announced that it has finalized an agreement with two of its lenders to restructure its $15.0 million Altmore, LLC (“Altmore”) Loan Agreement and its $17.0 million Reynold Greenleaf & Associates LLC (“R. Greenleaf”) Promissory Note, both previously due in February 2025. This improves the Company's financial position by extendi

Article Link